0001127602-24-022725.txt : 20240821
0001127602-24-022725.hdr.sgml : 20240821
20240821170240
ACCESSION NUMBER: 0001127602-24-022725
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240819
FILED AS OF DATE: 20240821
DATE AS OF CHANGE: 20240821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Witherspoon Charles
CENTRAL INDEX KEY: 0001731739
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08036
FILM NUMBER: 241229356
MAIL ADDRESS:
STREET 1: 530 HERMAN O WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC
CENTRAL INDEX KEY: 0000105770
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 231210010
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 6105942900
MAIL ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: WEST CO INC
DATE OF NAME CHANGE: 19990405
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-08-19
0000105770
WEST PHARMACEUTICAL SERVICES INC
WST
0001731739
Witherspoon Charles
530 HERMAN O. WEST DRIVE
EXTON
PA
19341
1
VP & Treasurer
0
Common Stock
2024-08-19
4
M
0
529
102.51
A
2507.141
D
Common Stock
2024-08-19
4
S
0
529
300.00
D
1978.141
D
Common Stock
2024-08-19
4
S
0
500
300.00
D
1478.141
D
Stock Options (Right to Buy)
102.51
2024-08-19
4
M
0
529
0
D
2020-02-19
2029-02-19
Stock Options (Right to Buy)
529
0
D
This award vested in four equal annual installments beginning on February 19, 2020.
/s/ Louis Lalli
2024-08-21
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): POA
LIMITED POWER OF ATTORNEY FOR
WEST PHARMACEUTICAL SERVICES, INC.
SECTION 16(a) FILINGS
Know all by these presents that the undersigned hereby constitutes and
appoints each of Luis Cantarero, Louis Lalli, Ryan Metz and
Caitlin Hippeli, signing singly, the undersigned?s true and lawful
attorney-in-fact to:
(1) Execute for and on behalf of the undersigned, in the undersigned?s
capacity as an officer, director and/or shareholder of West Pharmaceutical
Services, Inc. (the Company), Forms 3, 4, and 5 and amendments thereto
in accordance with Section 16(a) of the Securities Exchange Act of 1934 and
the rules thereunder;
(2) Do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5
or amendment thereto and timely file such form with the United States
Securities and Exchange Commission (the SEC) and any stock exchange or
similar authority; and
(3)Take any other action of any type whatsoever, which, in the opinion of such
attorney-in-fact, may be necessary or desirable in connection with the
foregoing authority, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and conditions
as such attorney-in-fact may approve.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and
powers herein granted, as fully to all intents and purposes as the undersigned
might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact,
or such attorney-in-fact?s substitute or substitutes, shall lawfully do or
cause to be done by virtue of this Power of Attorney and the rights and powers
herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming, nor is
the Company assuming, any of the undersigned?s responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to
the undersigned?s holdings of and transaction in securities of the Company,
unless earlier revoked by the undersigned in a signed writing delivered to
the foregoing attorneys-in-fact. This Power of Attorney may be filed with
the SEC as a confirming statement of the authority granted herein.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 15 day of May, 2024.
SIGNATURE
/s/ Charles Witherspoon